多国肠上皮化生突变特征与克隆性造血研究
该研究对来自六个国家的超过1500例肠上皮化生(IM)样本进行高深度靶向测序,识别出47个显著突变基因,包括ARID1A、KRAS/MAPK通路基因及PIGR。全基因组测序和DNA甲基化分析揭示SBS17为IM特异性突变特征,与晚期DNA复制、基因组低甲基化和烟草暴露相关。研究还发现IM患者克隆性造血(CH)升高,与年龄、吸烟及胃癌进展风险相关。
要点
- IM中识别出47个显著突变基因,包括ARID1A、KRAS/MAPK通路及PIGR。
- SBS17是区分IM与正常胃组织的特异性突变特征。
- IM患者克隆性造血升高,与年龄、吸烟和胃癌进展风险相关。
核心结论
- 肠上皮化生中存在复发性驱动基因突变、特异性突变特征SBS17及非上皮性克隆性造血改变,后者可能通过调节宿主-微生物黏膜免疫促进IM进展为胃癌。
研究设计与样本
- 对来自六个国家的超过1500例肠上皮化生样本进行高深度靶向测序。
- 对IM样本进行全基因组测序和DNA甲基化分析。
主要发现
- 识别出47个显著突变基因,包括与高风险人群和不良预后相关的ARID1A、KRAS/MAPK信号通路基因(KRAS、BRAF、MAP2K1、MAP3K1、MAP2K4)及黏膜免疫相关PIGR。
- SBS17突变特征可区分IM与正常胃组织,与晚期DNA复制、基因组低甲基化和烟草暴露相关。
- IM患者中克隆性造血升高,与年龄、吸烟及胃癌进展风险增加相关。
- 克隆性造血扩增的患者同时存在IM PIGR截短突变,且IM微环境中口腔来源细菌定植增加。
临床怎么用
- SBS17突变特征和克隆性造血可能作为IM进展风险的生物标志物,用于早期胃癌检测和干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Intestinal metaplasia (IM) is a premalignant condition associated with increased risk of gastric cancer-a deadly malignancy with varying geographic incidence. High-depth targeted sequencing of more than 1,500 IM samples from six countries identified 47 significantly mutated genes, including driver genes associated with high-risk populations and worse prognosis (ARID1A), KRAS/MAPK signaling (KRAS, BRAF, MAP2K1, MAP3K1, and MAP2K4), and altered mucosal immunity (PIGR). IM whole-genome sequencing and DNA methylation analysis revealed SBS17 as a specific mutational signature separating IMs from normal gastric tissues, associated with late DNA replication, genomic hypomethylation, and tobacco exposure. Beyond epithelial-derived somatic mutations, we observed elevated clonal hematopoiesis (CH) in patients with IM associated with age, smoking, and enhanced risk of progressing to gastric cancer. Patients with CH expansions exhibited co-occurring IM PIGR truncating mutations and greater colonization of the IM microenvironment by orally derived bacteria, suggesting that CH may promote IM progression by modulating host-microbe mucosal immunity. SIGNIFICANCE: This international study identifies recurrent IM driver genes, IM-specific mutational signatures, and alterations in IM-associated immune landscapes and microbiomes. Our results highlight a role for nonepithelial somatic alterations (CH) in IM progression to gastric cancer, offering new translational opportunities for early cancer detection and interception.
引用
- Huang KK, Hagihara T, Lian BSX, et al. Mutational Signatures and Clonal Hematopoiesis in Intestinal Metaplasia across Countries with Varying Stomach Cancer Incidence. Cancer Discov. 2026. PMID: 41532847. doi:10.1158/2159-8290.CD-25-0778
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。